Form 483

Novocure, Inc Form 483, 2024-02-09

FDA issued a Form 483 to Novocure, Inc on 2024-02-09 with 3 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health3 observations

Novocure, Inc · Portsmouth, United States · Issued February 9, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Feb 2024
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by James P Finn

9 Feb 2024
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by James P Finn

9 Feb 2024
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by James P Finn

Inspected site

NINovocure, IncPortsmouth, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.198(a)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere